| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.004 |